Home/Filings/4/0001323885-22-000023
4//SEC Filing

Dahlquist Karl S. 4

Accession 0001323885-22-000023

CIK 0001323885other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:30 PM ET

Size

8.1 KB

Accession

0001323885-22-000023

Insider Transaction Report

Form 4
Period: 2022-03-01
Dahlquist Karl S.
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2022-03-01+6,82530,439 total
  • Award

    Common Stock

    2022-03-01+7,78923,614 total
  • Tax Payment

    Common Stock

    2022-03-01$69.59/sh7,299$507,93723,140 total
Footnotes (3)
  • [F1]The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.
  • [F2]The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
  • [F3]The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001861996

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:30 PM ET
Size
8.1 KB